ACM
RMD icon

Aubrey Capital Management’s ResMed RMD Stock Holding History

Aubrey Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,600
Closed -$4.91M – 56
2020
Q2 		$4.91M Buy
25,600
+1,600
+7% +$262K 2.2% 17
2020
Q1 		$3.54M Hold
24,000
– – 2.19% 19
2019
Q4 		$3.72M Buy
+24,000
New +$3.46M 2.11% 24

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aubrey Capital Management's RMD Position: Q3 2020 in Review

Aubrey Capital Management sold out of ResMed (RMD) in Q3 2020, closing a stake of 25,600 shares — an estimated $4.91M sold.

Aubrey Capital Management first reported a position in RMD in Q4 2019 and held it in 3 quarters. The position peaked at $4.91M in Q2 2020. 626 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • Aubrey Capital Management reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
  • Aubrey Capital Management sold 25,600 ResMed shares in Q3 2020, an estimated $4.91M.
  • Aubrey Capital Management first reported a position in ResMed in Q4 2019 and held it in 3 quarters.
  • Aubrey Capital Management's ResMed position peaked at $4.91M in Q2 2020.
  • 626 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Aubrey Capital Management's 13F filing for Q3 2020, filed 29 Oct 2020.